Lumateperone Tosylate

lumateperone · ITI-007 sponsor (New York State Psychiatric Institute)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lumateperone Tosylate, covering 2021-11-02 to 2021-11-02. Get the full timeline:

Most recent: Clinical Trial Update: ITI-007 (Lumateperone Tosylate) for Schizophrenia [Phase 2]